References
- Takker U, Dzyublyk O, Busman T, Notario G. Comparison of 5 days of ER clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients. Curr Med Res Opin 2003;19:421–9
- Cytochrome P450 drug interaction table. Available at: http://medicine.iupui.edu/flockhart/. [Accessed 18 October 2003]
- Hersh EV, Moore PA. Drug interactions in dentistry: the importance of knowing your CYPs. JADA 2004;135 [in press]
- Dresser GK, Spence JD, Bailey DG. Pharmacokinetic–pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 2000;38: 41–57
- Hersh EV. Adverse drug interactions in dental practice: interactions with antibiotics. JADA 1999;130:236–51
- Michalets EL. Update: Clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 1998;18:84–112
- McCune JS, Hawke RL, LeCluyse EL, et al. In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone. Clin Pharmacol Ther 2000;68:356–66
- Honig P, Wortham D, Zamani K, Conner D, Cantilena L. Effect of erythromycin, clarithromycin and azithromycin on pharmacokinetics of terfenadine. Clin Pharmacol Ther 1993;53:161
- Krvisto KT, Neuvonen PJ, Klotz U. Inhibition of terfenadine metabolism: pharmacokinetic and pharmacodynamic consequences. Clin Pharmacokinet 1994;27:1–5
- Piquette RK. Torsades de pointes induced by cisapride/ clarithromycin interaction. Ann Pharmacother 1999;33:22–6
- van Haarst AD, van’t Klooster GA, van Gerven JM, et al. The influence of cisapride and clarithromycin on QT intervals in healthy volunteers. Clin Pharmacol Ther 1998; 64:542–6
- Desta Z, Kerbusch T, Flockhart DA. Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6). Clin Pharmacol Ther 1999;65: 10–20